Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(®) ) in neovascular age-related macular degeneration.

Autoria(s): Bonnin P.; Pournaras J.A.; Lazrak Z.; Cohen S.Y.; Legargasson J.F.; Gaudric A.; Levy B.I.; Massin P.
Data(s)

2010
Identificador

https://serval.unil.ch/?id=serval:BIB_5EFEFE6706ED

isbn:1755-3768 (Electronic)

pmid:19563370

doi:10.1111/j.1755-3768.2009.01526.x

isiid:000281310000014
Idioma(s)

en
Fonte

Acta Ophthalmologica, vol. 88, no. 6, pp. 641-645
Palavras-Chave #Aged; Aged, 80 and over; Angiogenesis Inhibitors/administration & dosage; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Blood Flow Velocity; Blood Pressure; Choroidal Neovascularization/drug therapy; Choroidal Neovascularization/physiopathology; Ciliary Arteries/physiology; Ciliary Arteries/ultrasonography; Female; Fluorescein Angiography; Heart Rate; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmic Artery/physiology; Ophthalmic Artery/ultrasonography; Pilot Projects; Retinal Artery/physiology; Retinal Artery/ultrasonography; Tomography, Optical Coherence; Ultrasonography, Doppler; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity/physiology; Wet Macular Degeneration/drug therapy; Wet Macular Degeneration/physiopathology
Tipo

info:eu-repo/semantics/article

article
Acesso ao item digital